Dr Ephraim W Aklilu, | |
58 W Portal Ave # 106, San Francisco, CA 94127-1304 | |
(510) 914-6903 | |
Not Available |
Full Name | Dr Ephraim W Aklilu |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 58 W Portal Ave # 106, San Francisco, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003063918 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 55180 (California) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Ephraim W Aklilu, 58 West Portal Avenue # 106, San Francisco, CA 94127-2187 Ph: (510) 914-6903 | Dr Ephraim W Aklilu, 58 W Portal Ave # 106, San Francisco, CA 94127-1304 Ph: (510) 914-6903 |
News Archive
An international study led by researchers from Université Laval and CHU de Québec-Université Laval has identified significant vascular changes in the brains of people with Huntington's disease. This breakthrough, the details of which are published in the most recent issue of Annals of Neurology, will have significant implications for our understanding of the disease and could open the door to new therapeutic targets for treating this fatal neurodegenerative condition.
For several decades, researchers have been linking genetic mutations to diseases ranging from cancer to developmental abnormalities. What hasn't been clear, however, is how the body's genome sustains such destructive glitches in the first place.
As cells with a propensity for cancer break down food for energy, they reach a fork in the road: They can either continue energy production as healthy cells, or shift to the energy production profile of cancer cells.
One of the nation's leading writers on the use of naturopathic medicine has released a new book documenting groundbreaking studies on modified citrus pectin (MCP) and its application for addressing serious health issues like cancer, heart disease, chronic inflammation and fibrosis.
› Verified 7 days ago